Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: A classic case of diminishing returns, and....ron
ease - I firmly believe that warrant conversion is the main reason for our depressed pps. Someone with MILLIONS of shares to sell has been doing just that and I do not believe it is the average retail investor. Our revenue stream is far better than some companies who sell for 10X what our pps is... even if our only source of income turned out to be the MMP (which I doubt highly) we should still be selling at a much higher multiple considering there are at least 300 more companies yet to license the MMP. PE's are based on FUTURE earnings, and we are not getting that valuation at all. Of course, adding another source of revs, through acquisition, partnership or marketing of the ignite family, would give us a significant boost in the pps as ronran has indicated.

Dec 21, 2006 04:30AM
Share
New Message
Please login to post a reply